InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
0
T+90 胜率
100%
T+90 平均收益
+4.9%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
无可用的信号评分。
Browse the full record of transactions filed by Greene Nefertiti, Membre du Conseil. Insider active across 1 company, notably UCB. Cumulatively, 1 filings have been recorded. Activity tracked since 5 November 2025. The latest transaction was disclosed on 5 November 2025 (Purchase). Regulator: FSMA. All data is openly available.
Companies and markets linked to Greene Nefertiti
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报1 总计
200 股@ €216.10100.0% 占其流量ShareEuronext BrusselsISIN BE0003739530FSMA:ucb-10
1 条申报中的 1 条
About Greene Nefertiti
Nefertiti Greene is a member of the administrative management at UCB, a global biopharmaceutical company. In her role, she participates in strategic decision-making and oversight of operations, contributing to the company's mission to improve patients' lives. Her expertise in the pharmaceutical sector is a valuable asset for UCB as she strives to meet industry challenges and innovate in the development of new treatments.
